Yang Peng

2.6k total citations · 2 hit papers
27 papers, 1.4k citations indexed

About

Yang Peng is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Yang Peng has authored 27 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 12 papers in Oncology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Yang Peng's work include DNA Repair Mechanisms (7 papers), PARP inhibition in cancer therapy (5 papers) and Cancer Mechanisms and Therapy (3 papers). Yang Peng is often cited by papers focused on DNA Repair Mechanisms (7 papers), PARP inhibition in cancer therapy (5 papers) and Cancer Mechanisms and Therapy (3 papers). Yang Peng collaborates with scholars based in United States, China and Hungary. Yang Peng's co-authors include Guang Peng, Gordon B. Mills, Jianfeng Shen, Zhenlin Ju, Lulu Wang, Timothy A. Yap, Wei Zhao, Marilyne Labrie, Qianxing Mo and Shiaw‐Yih Lin and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Yang Peng

24 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

PARPi Triggers the STING-Dependent Immune Response and Enhances the Therapeutic Efficacy of Immune Checkpoint Blockade Independent of BRCAness

2018 427 citations Jianfeng Shen, Wei Zhao et al. Cancer Research profile →
ARID1A Deficiency Impairs the DNA Damage Checkpoint and Sensitizes Cells to PARP Inhibitors

2015 358 citations Jianfeng Shen, Yang Peng et al. Cancer Discovery profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yang Peng United States	12	906	789	287	229	216	27	1.4k
Oday Hamid United States	15	669 0.7×	685 0.9×	175 0.6×	211 0.9×	123 0.6×	41	1.2k
Laura Stanbery United States	17	441 0.5×	557 0.7×	273 1.0×	85 0.4×	242 1.1×	54	1.1k
Sander R. van Hooff Netherlands	16	528 0.6×	362 0.5×	164 0.6×	140 0.6×	223 1.0×	29	1.0k
Marcin Krzystanek Denmark	15	733 0.8×	753 1.0×	105 0.4×	157 0.7×	611 2.8×	21	1.4k
Vinod Vathipadiekal United States	16	709 0.8×	286 0.4×	130 0.5×	165 0.7×	301 1.4×	23	1.2k
Mei‐Kuang Chen United States	12	527 0.6×	912 1.2×	348 1.2×	45 0.2×	131 0.6×	24	1.2k
Saeed Rafii United Kingdom	13	516 0.6×	1.0k 1.3×	242 0.8×	92 0.4×	194 0.9×	34	1.5k
Johanne I. Weberpals Canada	20	687 0.8×	619 0.8×	101 0.4×	127 0.6×	289 1.3×	56	1.3k
Therese Törngren Sweden	15	555 0.6×	605 0.8×	263 0.9×	114 0.5×	313 1.4×	26	1.1k
Ecaterina E. Dumbrava United States	17	379 0.4×	647 0.8×	185 0.6×	89 0.4×	194 0.9×	115	1.0k

Countries citing papers authored by Yang Peng

Since Specialization

Citations

This map shows the geographic impact of Yang Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yang Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yang Peng more than expected).

Fields of papers citing papers by Yang Peng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yang Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yang Peng. The network helps show where Yang Peng may publish in the future.

Co-authorship network of co-authors of Yang Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Yang Peng. A scholar is included among the top collaborators of Yang Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yang Peng. Yang Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Peng, Yang, Mauro Di Pilato, Jianjun Zhang, et al.. (2025). Accurate imputation of pathway-specific gene expression in spatial transcriptomics with PASTA. Nature Communications. 17(1). 726–726.

Zhao, Yuansong, Yang Peng, Glen Laird, Josh Chen, & Ying Yuan. (2025). PS-SAM: propensity-score-integrated self-adapting mixture prior to dynamically and efficiently borrow information from historical data. Journal of Biopharmaceutical Statistics. 35(6). 1067–1082.

Li, Xin, Nan Chen, Zhaoya Gao, et al.. (2025). HDAC and MEK inhibition synergistically suppresses HOXC6 and enhances PD-1 blockade efficacy in BRAF^V600E-mutant microsatellite stable colorectal cancer. Journal for ImmunoTherapy of Cancer. 13(1). e010460–e010460. 4 indexed citations

Chowdhury, Shrabanti, Sammy Ferri‐Borgogno, Yang Peng, et al.. (2025). Learning directed acyclic graphs for ligands and receptors based on spatially resolved transcriptomic data of ovarian cancer. Briefings in Bioinformatics. 26(2).

Bahrambeigi, Vahid, Jaewon J. Lee, Vittorio Branchi, et al.. (2024). Transcriptomic Profiling of Plasma Extracellular Vesicles Enables Reliable Annotation of the Cancer-Specific Transcriptome and Molecular Subtype. Cancer Research. 84(10). 1719–1732. 6 indexed citations

Peng, Yang, Daniel Li, Ruitao Lin, Bo Huang, & Ying Yuan. (2024). Design and sample size determination for multiple‐dose randomized phase II trials for dose optimization. Statistics in Medicine. 43(15). 2972–2986. 9 indexed citations

Peng, Yang, et al.. (2023). SAM: Self-Adapting Mixture Prior to Dynamically Borrow Information from Historical Data in Clinical Trials. Biometrics. 79(4). 2857–2868. 9 indexed citations

Robinson, Prema, Emma Rodrı́guez, Yang Peng, et al.. (2023). Therapeutic Potential of a Small-Molecule STAT3 Inhibitor in a Mouse Model of Colitis. Cancers. 15(11). 2977–2977. 8 indexed citations

Wang, Lulu, Lin Yang, Chen Wang, et al.. (2020). Inhibition of the ATM/Chk2 axis promotes cGAS/STING signaling in ARID1A-deficient tumors. Journal of Clinical Investigation. 130(11). 5951–5966. 87 indexed citations

10.

Shen, Jianfeng, Wei Zhao, Zhenlin Ju, et al.. (2018). PARPi Triggers the STING-Dependent Immune Response and Enhances the Therapeutic Efficacy of Immune Checkpoint Blockade Independent of BRCAness. Cancer Research. 79(2). 311–319. 427 indexed citations breakdown →

11.

Chang, Lufen, Hu Zhou, Jing Gao, et al.. (2018). ITCH nuclear translocation and H1.2 polyubiquitination negatively regulate the DNA damage response. Nucleic Acids Research. 47(2). 824–842. 18 indexed citations

12.

Kumar, Sandeep, Xiangdong Peng, James M. Daley, et al.. (2017). Inhibition of DNA2 nuclease as a therapeutic strategy targeting replication stress in cancer cells. Oncogenesis. 6(4). e319–e319. 53 indexed citations

13.

Zhang, Lihong, Yang Peng, Iván P. Uray, et al.. (2017). Natural product β-thujaplicin inhibits homologous recombination repair and sensitizes cancer cells to radiation therapy. DNA repair. 60. 89–101. 11 indexed citations

14.

Zhang, Lihong, Jianfeng Shen, Yuping Yin, et al.. (2017). Identifying Cell Cycle Modulators That Selectively Target ARID1A Deficiency Using High-Throughput Image-Based Screening. SLAS DISCOVERY. 22(7). 813–826. 7 indexed citations

15.

Peng, Yang, et al.. (2017). Dissect the Dynamic Molecular Circuits of Cell Cycle Control through Network Evolution Model. BioMed Research International. 2017. 1–9. 1 indexed citations

16.

Mo, Wei, Qingxin Liu, Curtis Chun-Jen Lin, et al.. (2015). mTOR Inhibitors Suppress Homologous Recombination Repair and Synergize with PARP Inhibitors via Regulating SUV39H1 in BRCA-Proficient Triple-Negative Breast Cancer. Clinical Cancer Research. 22(7). 1699–1712. 90 indexed citations

17.

Shen, Jianfeng, Yang Peng, Leizhen Wei, et al.. (2015). ARID1A Deficiency Impairs the DNA Damage Checkpoint and Sensitizes Cells to PARP Inhibitors. Cancer Discovery. 5(7). 752–767. 358 indexed citations breakdown →

18.

Peng, Yang, Wen Dong, Tianxin Lin, et al.. (2015). MicroRNA-155 promotes bladder cancer growth by repressing the tumor suppressor DMTF1. Oncotarget. 6(18). 16043–16058. 49 indexed citations

19.

Peng, Yang, Hui Dai, Wenge Wang, et al.. (2014). TUSC4 Functions as a Tumor Suppressor by Regulating BRCA1 Stability. Cancer Research. 75(2). 378–386. 26 indexed citations

20.

Peng, Guang, Curtis Chun-Jen Lin, Wei Mo, et al.. (2014). Genome-wide transcriptome profiling of homologous recombination DNA repair. Nature Communications. 5(1). 3361–3361. 161 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact